Predkongresni simpozij Bled 2014

14. maj 2014

Vabljeni na Predkongresni simpozij Bled, ki bo potekal 14. maja 2014 med 10. in 18. uro v Festivalni dvorani Bled.

Precongress symposium: Molecular diagnostics and targeted therapy in NSCLC

Festivalna dvorana, Bled, Slovenia
Wednesday, May 14, 2014

Program

Wednesday, May 14

Chairpersons: Tanja Čufer (Slovenia), Izidor Kern (Slovenia)
10.00-10.30 Update in targeted therapy of NSCLC
Tanja Čufer (Slovenia)
10.30-11.00 Molecular testing of resistance mechanisms in NSCLC
Helmut Popper (Austria)
11.00-11.30 Sponsored symposium Boehringer Ingelheim
Improving management of advanced NSCLC

2nd generation irreversible ErbB family blocker LUXlung3 and LUXlung6 clinical studies: efficacy and patient quality of life considerations
Tanja Čufer (Slovenia)

Triple angiokinase inhibitor therapy for advanced NSCLC in the second-line setting
Marko Jakopović (Croatia)

11.30-12.00 Coffee Break
12.30-12.30 Targeted therapy in Central Europe
Robert Pirker (Austria)
12.30-13.00 External quality assurance in molecular testing of NSCLC
Ulrike Gruber Mösenbacher (Austria)
13.00-13.15 Sponsored symposium Astra Zeneca
Clinical value of immunohistochemistry as an alternative method of EGFR mutation detection
Nina Turnšek Hitij (Slovenia)
13.15-14.30 Lunch
Chairpersons: Robert Pirker (Austria), Ales Ryska (Czech Republic)
14.30-15.00 ALK testing algorithms and Czech registry of NSCLC
Ales Ryska (Czech Republic)
15.00-15.30 Sponsored symposium Bioview – Abbott Vysis FISH automation – expanding your laboratory focus
Dennis Merkle, Elad Kfir
15.30-16.00 Promising targeted drugs for NSCLC
Peter Beržinec (Slovakia)
16.00-16.30 Coffee break
16.30-17.00 Case presentations
Luka Brčić, Marko Jakopović (Croatia)
Istvan Petak (Hungary)
17.00-17.10 Lung cancer morphologic diagnostic guidelines – Czech experience
Ales Ryska (Czech Republic)
17.10-17.30 Sponsored symposium Eli Lilly
The role of histology in the treatment of advanced NSCLC
Katja Mohorčič (Slovenia)